CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host
its second quarter 2011 investor update conference call and webcast at
8:30 a.m. Eastern Time on Thursday, August 11, 2011. Individuals
interested in participating in the call should dial (877) 847-5946 (U.S.
and Canada) or (970) 315-0447 (international) using conference ID number
90255369. To access the webcast, please visit the Investors section of
Ironwood's website at www.ironwoodpharma.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
The call will be available for replay via telephone starting August 11,
2011, at approximately 11:30 a.m. Eastern Time, running through 11:59
p.m. Eastern Time on August 25, 2011. To listen to the replay, dial
(855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international) using
conference ID number 90255369. The archived webcast will be available on
Ironwood's website for 14 days beginning approximately one hour after
the call.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC-C agonist, is an investigational
drug for the treatment of irritable bowel syndrome with constipation
(IBS-C) and chronic constipation. The efficacy portion of linaclotide's
development program has been completed and will support the NDA
submission for both indications, as well as the MAA submission for the
IBS-C indication. Ironwood also has a growing pipeline of additional
drug candidates in earlier stages of development. Ironwood is located in
Cambridge, Mass. To learn more, visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals, Inc.
Susan Brady, 617-621-8304
Corporate
Communications
sbrady@ironwoodpharma.com
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media